CluePoints Inc.

10 articles about CluePoints Inc.

• CluePoints’ Risk-Based Quality Management (RBQM) Software Wins Best Technological Development in Clinical Trials at SCRIP Awards 2019

  12/5/2019

  CluePoints, the premier provider of Risk-Based Study Execution and Risk-Based Quality Management Software for clinical trials, announced that it has been awarded best technological development in clinical trials in the 2019 Scrip Awards.

• As Demand for RBx Soars CluePoints Continues Global Expansion Alongside Further Award Wins

  10/22/2019

  CluePoints, the premier provider of Risk-Based Study Execution and Data Quality Oversight Software for clinical trials, announced major expansion as it bolsters its offering with two new larger offices to accommodate its growing family of employees and contractors.

• FDA Extends CRADA with CluePoints to Further Explore a Data-Driven Approach to Quality Oversight in Clinical Trials

  9/10/2019

  FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical research.

• CluePoints Strengthens Senior Team with Two Key Appointments

  10/2/2018

  CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced the appointment of two industry thought-leaders to its senior team, as it continues its impressive global growth throughout North America, Europe and Asia Pacific. Richard Davies joins as VP, Solutions Expert, and Suzanne Lukac as Senior Account Director.

• Quanticate partners with CluePoints to offer Data Quality Oversight capabilities

  9/25/2018

  Quanticate, has announced that it has partnered with CluePoints™ to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the  amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelines.

• CluePoints Wins Best Risk-Based Monitoring Solution in 2018 Biotechnology Awards

  1/31/2018

  CluePoints has been honoured in this year’s Biotechnology Awards with the CluePoints solution being named the "Best Risk-Based Monitoring Solution".

• CluePoints Launches Risk-Based Monitoring Starter Pack to Drive Regulatory Compliance

  1/22/2018

  The starter pack has been developed following CluePoints' extensive market and industry research to better understand the challenges faced by clinical development organizations and CROs since the introduction of the ICH E6 (R2) addendum.

• CluePoints Responds to Sponsor and CRO Demand with Two New Appointments

  12/5/2017

  CluePoints, a leading provider of RBM and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen its business development team.

• CluePoints Builds on Late Phase Work in Japan and Launches Risk-Based Monitoring Roadshow in Tokyo

  11/3/2017

  The collaborations mark the latest success for CluePoints in the region, with its centralized statistical monitoring (CSM) platform having already been used by the Nagoya University School of Medicine for an eight-year Phase III Stomach Cancer Adjuvant Multi-Institutional Group Trial (SAMIT).

• CluePoints Inc. Opens U.S. Office

  5/2/2017